Ask
Search
My library

About
Statistics
Contact
Data Protection
Accessibility
Imprint
Changelog
Frontend: v1.31.3
Backend: v1.11.4

We use cookies to provide a better user experience.

Data Protection

Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients

Wezel, E.M. van
Decarolis, B.
Stutterheim, J.
Zappeij-Kannegieter, L.
Berthold, F.
Schumacher-Kuckelkorn, R.
Simon, T.
Fiocco, M.
Noesel, M.M. van
Caron, H.N.
Schoot, C.E. van der
Hero, B.
Tytgat, G.A.M.

Publication date

February 2016

DOI

10.1016/j.ejca.2015.11.007

Publisher

Elsevier BV

Abstract

Development and application of statistical models for medical scientific researc

Extracted data

Related items

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force

Beiske, K
Burchill, SA
Cheung, IY
Hiyama, E
Seeger, RC
Cohn, SL
Pearson, ADJ
Matthay, KK

May 2009

Disseminating disease is a predictive and prognostic indicator of poor outcome in children with neur...

Recommendations for the Standardization of Bone Marrow Disease Assessment and Reporting in Children With Neuroblastoma on Behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group

Burchill, Susan A.
Beiske, Klaus
Shimada, Hiroyuki
Ambros, Peter F.
Seeger, Robert
Tytgat, Godelieve A. M.
Brock, Penelope R.
Haber, Michelle
Park, Julie R.
Berthold, Frank

January 2017

BACKGROUND: The current study was conducted to expedite international standardized reporting of bone...

Immunocytochemical detection of neuroblastoma cells infiltrating clinical bone marrow samples

Beck, D.
Maritaz, O.
Gross, N.
Favrot, M.
Vultier, N.
Bailly, C.
Villa, I.
Gentilhomme, O.
Philip, T.

August 1988

To evaluate the feasibility and clinical usefulness of immunocytochemical detection of bone marrow m...

PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers – Focus on neuroblastoma

Brownhill, Sam C.
Burchill, Sue A.

April 2016

AbstractMetastatic disease is a major challenge for cancer cure, haematogenous spread and subsequent...

Systems analysis of nucleic acids to model outcome and biological characteristics of neuroblastoma

Haunch-Smith, Charlotte Mary

September 2018

Neuroblastoma (NB) cells in the bone marrow (BM) at diagnosis are powerful indicators of poor outcom...

The use of molecular-biology methods (QRT-PCR) and immunocytological methods (flow cytometry and immunocytochemistry) for the detection of minimal residual disease in neuroblastoma

Grüncveigová, Veronika

January 2017

With a continuous development of molecular-biology methods more attention has been paid to molecular...

Minimal residual disease monitoring in neuroblastoma

van Wezel, E.M.

January 2016

Neuroblastoma is the third most common childhood cancer. The presence of metastatic spread at diagno...

Level of Seven Neuroblastoma-Associated mRNAs Detected by Droplet Digital PCR Is Associated with Tumor Relapse/Regrowth of High-Risk Neuroblastoma Patients

Thwin, Khin K. M.
Ishida, Toshiaki
Uemura, Suguru
Yamamoto, Nobuyuki
Lin, Kyaw S.
Tamura, Akihiro
Kozaki, Aiko
Saito, Atsuro
Kishimoto, Kenji
Mori, Takeshi
Hasegawa, Daiichiro
Kosaka, Yoshiyuki
Nino, Nanako
Takafuji, Satoru
Iijima, Kazumoto
Nishimura, Noriyuki

February 2020

Monitoring of several sets of neuroblastoma-associated mRNAs (NB-mRNAs) by real-time quantitative PC...

Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR

Druy, Alexander E.
Shorikov, Egor V.
Tsaur, Grigory A.
Popov, Alexander M.
Zaychikov, Artem N.
Tuponogov, Sergey N.
Saveliev, Leonid I.
Tytgat, Godelieve A. M.
Fechina, Larisa G.

January 2018

Background: Detection of bone marrow (BM) involvement in patients with neuroblastoma is crucial for ...

PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers – Focus on neuroblastoma

Brownhill, Sam C.
Burchill, Sue A.

April 2016

AbstractMetastatic disease is a major challenge for cancer cure, haematogenous spread and subsequent...

PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers – Focus on neuroblastoma

Brownhill, SC
Burchill, SA

April 2017

Metastatic disease is a major challenge for cancer cure, haematogenous spread and subsequent growth ...

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.

Beiske, K
Burchill, SA
Cheung, IY
Hiyama, E
Seeger, RC
Cohn, SL
Pearson, ADJ
Matthay, KK
International neuroblastoma Risk Group Task Force

May 2009

Disseminating disease is a predictive and prognostic indicator of poor outcome in children with neur...

Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma; on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group

Burchill, SA
Beiske, K
Shimada, H
Ambros, PF
Seeger, R
Tytgat, GAM
Brock, PR
Haber, M
Park, JR
Berthold, F

April 2017

BACKGROUND: The current study was conducted to expedite international standardized reporting of bone...

Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic Biomarkers

Merugu, S
Chen, L
Gavens, E
Gabra, H
Brougham, M
Makin, G
Ng, A
Murphy, D
Gabriel, AS
Robinson, ML
Wright, JH
Burchill, SA
Humphreys, A
Bown, N
Jamieson, D
Tweddle, DA

January 2020

PURPOSE: Circulating tumor cells (CTCs) serve as noninvasive tumor biomarkers in many types of canc...

Expression of Neuroblastoma-Related Genes in Bone Marrow at End of High-Risk Neuroblastoma Therapy

Asgharzadeh, Shahab
Marachelian, Araz
Villablanca, Judith G
Liu, Wei Yao
Kennedy, Rebekah
Sposto, Richard
Naranjo, Arlene
Tenney, Sheena
Yu, Alice L
Ozkaynak, M Fevzi
Sondel, Paul M
Park, Julie R
Seeger, Robert C

September 2022

BACKGROUND: Minimal disease quantification may predict event-free survival (EFS) and overall surviva...

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force

Beiske, K
Burchill, SA
Cheung, IY
Hiyama, E
Seeger, RC
Cohn, SL
Pearson, ADJ
Matthay, KK

May 2009

Disseminating disease is a predictive and prognostic indicator of poor outcome in children with neur...

Recommendations for the Standardization of Bone Marrow Disease Assessment and Reporting in Children With Neuroblastoma on Behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group

Burchill, Susan A.
Beiske, Klaus
Shimada, Hiroyuki
Ambros, Peter F.
Seeger, Robert
Tytgat, Godelieve A. M.
Brock, Penelope R.
Haber, Michelle
Park, Julie R.
Berthold, Frank

January 2017

BACKGROUND: The current study was conducted to expedite international standardized reporting of bone...

Immunocytochemical detection of neuroblastoma cells infiltrating clinical bone marrow samples

Beck, D.
Maritaz, O.
Gross, N.
Favrot, M.
Vultier, N.
Bailly, C.
Villa, I.
Gentilhomme, O.
Philip, T.

August 1988

To evaluate the feasibility and clinical usefulness of immunocytochemical detection of bone marrow m...

PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers – Focus on neuroblastoma

Brownhill, Sam C.
Burchill, Sue A.

April 2016

AbstractMetastatic disease is a major challenge for cancer cure, haematogenous spread and subsequent...

Systems analysis of nucleic acids to model outcome and biological characteristics of neuroblastoma

Haunch-Smith, Charlotte Mary

September 2018

Neuroblastoma (NB) cells in the bone marrow (BM) at diagnosis are powerful indicators of poor outcom...

The use of molecular-biology methods (QRT-PCR) and immunocytological methods (flow cytometry and immunocytochemistry) for the detection of minimal residual disease in neuroblastoma

Grüncveigová, Veronika

January 2017

With a continuous development of molecular-biology methods more attention has been paid to molecular...

Minimal residual disease monitoring in neuroblastoma

van Wezel, E.M.

January 2016

Neuroblastoma is the third most common childhood cancer. The presence of metastatic spread at diagno...

Level of Seven Neuroblastoma-Associated mRNAs Detected by Droplet Digital PCR Is Associated with Tumor Relapse/Regrowth of High-Risk Neuroblastoma Patients

Thwin, Khin K. M.
Ishida, Toshiaki
Uemura, Suguru
Yamamoto, Nobuyuki
Lin, Kyaw S.
Tamura, Akihiro
Kozaki, Aiko
Saito, Atsuro
Kishimoto, Kenji
Mori, Takeshi
Hasegawa, Daiichiro
Kosaka, Yoshiyuki
Nino, Nanako
Takafuji, Satoru
Iijima, Kazumoto
Nishimura, Noriyuki

February 2020

Monitoring of several sets of neuroblastoma-associated mRNAs (NB-mRNAs) by real-time quantitative PC...

Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR

Druy, Alexander E.
Shorikov, Egor V.
Tsaur, Grigory A.
Popov, Alexander M.
Zaychikov, Artem N.
Tuponogov, Sergey N.
Saveliev, Leonid I.
Tytgat, Godelieve A. M.
Fechina, Larisa G.

January 2018

Background: Detection of bone marrow (BM) involvement in patients with neuroblastoma is crucial for ...

PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers – Focus on neuroblastoma

Brownhill, Sam C.
Burchill, Sue A.

April 2016

AbstractMetastatic disease is a major challenge for cancer cure, haematogenous spread and subsequent...

PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers – Focus on neuroblastoma

Brownhill, SC
Burchill, SA

April 2017

Metastatic disease is a major challenge for cancer cure, haematogenous spread and subsequent growth ...

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.

Beiske, K
Burchill, SA
Cheung, IY
Hiyama, E
Seeger, RC
Cohn, SL
Pearson, ADJ
Matthay, KK
International neuroblastoma Risk Group Task Force

May 2009

Disseminating disease is a predictive and prognostic indicator of poor outcome in children with neur...

Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma; on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group

Burchill, SA
Beiske, K
Shimada, H
Ambros, PF
Seeger, R
Tytgat, GAM
Brock, PR
Haber, M
Park, JR
Berthold, F

April 2017

BACKGROUND: The current study was conducted to expedite international standardized reporting of bone...

Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic Biomarkers

Merugu, S
Chen, L
Gavens, E
Gabra, H
Brougham, M
Makin, G
Ng, A
Murphy, D
Gabriel, AS
Robinson, ML
Wright, JH
Burchill, SA
Humphreys, A
Bown, N
Jamieson, D
Tweddle, DA

January 2020

PURPOSE: Circulating tumor cells (CTCs) serve as noninvasive tumor biomarkers in many types of canc...

Expression of Neuroblastoma-Related Genes in Bone Marrow at End of High-Risk Neuroblastoma Therapy

Asgharzadeh, Shahab
Marachelian, Araz
Villablanca, Judith G
Liu, Wei Yao
Kennedy, Rebekah
Sposto, Richard
Naranjo, Arlene
Tenney, Sheena
Yu, Alice L
Ozkaynak, M Fevzi
Sondel, Paul M
Park, Julie R
Seeger, Robert C

September 2022

BACKGROUND: Minimal disease quantification may predict event-free survival (EFS) and overall surviva...

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force

Beiske, K
Burchill, SA
Cheung, IY
Hiyama, E
Seeger, RC
Cohn, SL
Pearson, ADJ
Matthay, KK

May 2009

Disseminating disease is a predictive and prognostic indicator of poor outcome in children with neur...

Recommendations for the Standardization of Bone Marrow Disease Assessment and Reporting in Children With Neuroblastoma on Behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group

Burchill, Susan A.
Beiske, Klaus
Shimada, Hiroyuki
Ambros, Peter F.
Seeger, Robert
Tytgat, Godelieve A. M.
Brock, Penelope R.
Haber, Michelle
Park, Julie R.
Berthold, Frank

January 2017

BACKGROUND: The current study was conducted to expedite international standardized reporting of bone...

Immunocytochemical detection of neuroblastoma cells infiltrating clinical bone marrow samples

Beck, D.
Maritaz, O.
Gross, N.
Favrot, M.
Vultier, N.
Bailly, C.
Villa, I.
Gentilhomme, O.
Philip, T.

August 1988

To evaluate the feasibility and clinical usefulness of immunocytochemical detection of bone marrow m...